JAOA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


JAOA • Vol 101 • No 12_suppl_2 • December 2001 • 1-6
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orenstein, R
Right arrow Articles by Tsogas, N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orenstein, R
Right arrow Articles by Tsogas, N

Hepatitis C virus and human immunodeficiency virus co-infection in women

R Orenstein; N Tsogas

Women account for almost one of four newly diagnosed cases of the human immunodeficiency virus (HIV) infection in the United States. It is believed that up to 20% of them are co-infected with hepatitis C virus (HCV). AIDS is now the third leading cause of death in women aged 25 to 44 years in the United States. The ability to better control the HIV infection and improve survival among the co-infected population will make managing chronic liver disease due to hepatitis C the next clinical challenge for these women. This article reviews the available data and summarizes the primary care approach to the female patient with HCV-HIV co-infection.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Osteopathic Association.